Georgia Prevention Institute at Medical College of Georgia
Augusta, Georgia, 30912, United States
NCT Number: NCT00909454
The purpose of this study is to determine if 14-19 year old African American adolescents are able to take a daily vitamin D supplement daily for about 4 months and how well a daily dose of 400 IU or 2000 IU vitamin D supplement raises their vitamin D blood level.
Looking for future studies?
Notify Me14 year–19 year
All sexes
Interventional
Not applicable
Augusta, Georgia, 30912, United States
To determine the feasibility of African American teenagers taking a daily vitamin D supplement over a 4 month period in terms of compliance and practical implementation.
To determine the differences in response in blood 25-OH D level between those randomly assigned to taking a 400 IU supplement versus 2000 IU per day and to determine if there are differences in blood 25-OH D level response depending on subject gender and overweight/obese versus healthy-weight status.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2000 IU vitamin D3 supplement to be taken once daily over 4 months
Other names: NatureMade Maximum Strength D Vitamin 2000 IU List NO. 2516
400 IU Vitamin D3 supplement to be taken daily over 4 months
Other names: NatureMade D Vitamin 400 IU List No. 1688
Time frame: 3-4 months from baseline to post-testing
Time frame: 3-4 months from baseline to post-testing
Augusta University
Other
V.I.P. Feasibility Study (Vitamin D Intake Project)
Acronym: VIP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03344718
Atrophy, Avitaminosis
Tainan, Taiwan
View Trial DetailsNCT07275177
Age-Related Loss of Skeletal Muscle Mass, Aging
Miahuatlán de Porfirio Díaz, Oaxaca, Mexico
View Trial DetailsNCT04979065
Avitaminosis, Body Weight
Jakarta, DKI Jakarta, Indonesia
View Trial DetailsNCT04377386
Avitaminosis, Body Weight
Floridablanca, Santander Department, Colombia
View Trial Details